AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Healthcare CMO Market to 2027- Global Analysis & Outlook by Service and Geography - ResearchAndMarkets.com

April 11, 2019

DUBLIN--(BUSINESS WIRE)--Apr 11, 2019--The “Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service; and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is estimated to grow with a CAGR of 12.2% from 2019-2027.

The market is driven by the factors such as, increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices. However, the challenge such as lack of skilled professionals for CMO likely to impact the growth of the market in the forecast period.

Increasing patent cliffs are likely to grow market dynamically. The rising numbers of the contract manufacturing across the globe are entering in the production of the generic drugs as the legislation encouraged competition to benefit consumers. The CMOs help in the manufacturing the drug with the bioequivalence testing and the drugs are produced with the current good manufacturing practices. The CMO allows to reduce the cost of manufacturing and enhance the production in bulk quantities.

Additionally as per the paper’s statistics it is stated that approximately US$ 194 billion in the innovative drugs sales are at risk during the 2017-2020. Also an estimate of nearly US$ 31 billion could be lost due to the expiry of patents alone in 2018. Therefore, owing to the above mentioned factors the market for the healthcare CMO is likely to propel during the forecast period.

Global healthcare CMO market, based on service was segmented into major segments such as pharmaceutical contract manufacturing services and medical device contract manufacturing services. The pharmaceutical contract manufacturing services segment is expected to dominate the market in 2027, owing to the advantages provided by the contract manufacturing organizations and he rising prevalence of chronic and acute disease across the world. In addition, the segment is also anticipated to witness the fastest growth rate during the forecast period, 2018 to 2027.

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Healthcare CMO Market - by Service

1.3.2 Global Healthcare CMO Market - by Geography

2. Global Healthcare CMO Market - Key Takeaways

3. Research Methodology

3.1.1 Coverage

3.1.2 Secondary Research

3.1.3 Primary Research

4. Global Healthcare CMO - Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America - Pest Analysis

4.2.2 Europe - Pest Analysis

4.2.3 Asia Pacific - Pest Analysis

4.2.4 Middle East & South Africa - Pest Analysis

4.2.5 South and Central America - Pest Analysis

5. Global Healthcare CMO Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Inclination of Pharmaceutical and Medical Device Manufacturers Towards Outsourcing

5.1.2 Increasing Patent Cliffs

5.1.3 Rising Geriatric Population Coupled With the Increasing Production of Drugs & Medical Devices

5.2 Key Market Challenges

5.2.1 Lack of Skilled Professionals For CMO

5.3 Key Market Opportunities

5.3.1 Rising Demand In Developing Regions

5.3.2 Growth Opportunities Due To Biosimilars Market

5.4 Market Trend

5.4.1 Rise In Market Consolidation

5.5 Impact Analysis

6. Healthcare CMO Market - Global Analysis

6.1 Global Healthcare CMO Market Revenue Forecasts and Analysis

6.2 Global Healthcare CMO Market, by Geography - Forecasts and Analysis

6.3 Performance of Key Players

6.3.1 Catalent Inc.

6.3.2 Lonza

6.3.3 Integer Holdings Corporation

6.3.4 Flex Ltd.

6.4 Expert Opinions

7. Global Healthcare CMO Market Analysis - by Service

7.1 Overview

7.2 Global Healthcare CMO Market by Service, 2018 & 2027 (%)

7.3 Pharmaceutical Contract Manufacturing Services Market

7.3.1 Overview

7.3.2 Global Pharmaceutical Contract Manufacturing Services Market Revenue and Forecasts To 2027 (US$ Mn)

7.3.3 Active Pharmaceutical Ingredients (API) Market

7.3.3.1 Overview

7.3.3.2 Global Active Pharmaceutical Ingredients (API) Market Revenue and Forecasts To 2027 (US$ Mn)

7.3.4 Final Dosage Form Manufacturing Market

7.3.4.1 Overview

7.3.4.2 Global Final Dosage Form Manufacturing Market Revenue and Forecasts To 2027 (US$ Mn)

7.3.5 Packaging Market

7.3.5.1 Overview

7.3.5.2 Global Packaging Market Revenue and Forecasts To 2027 (US$ Mn)

7.4 Medical Device Contract Manufacturing Services Market

7.4.1 Overview

7.4.2 Global Medical Device Contract Manufacturing Market Revenue and Forecasts To 2027 (US$ Mn)

7.4.3 Outsourcing Design Market

7.4.3.1 Overview

7.4.3.2 Global Outsourcing Design Market Revenue and Forecasts To 2027 (US$ Mn)

7.4.4 Device Manufacturing Market

7.4.4.1 Overview

7.4.4.2 Global Device Manufacturing Market Revenue and Forecasts To 2027 (US$ Mn)

7.4.5 Final Goods Assembly Market

7.4.5.1 Overview

7.4.5.2 Global Final Goods Assembly Market Revenue and Forecasts To 2027 (US$ Mn)

8. Healthcare CMO Market Revenue and Forecasts To 2027 - Geographical Analysis

8.1 North America Healthcare CMO Market

8.2 Europe Healthcare CMO Market

8.3 Asia Pacific Healthcare CMO Market

8.4 Middle East & Africa Healthcare CMO Market

8.5 South and Central America Healthcare CMO Market

9. Healthcare CMO Market -Industry Landscape

9.1 Overview

9.2 Growth Strategies In the Healthcare CMO Market, 2015-2018

9.3 Organic Developments

9.4 Organic Growth Strategies In the Healthcare CMO Market, 2016-2018

9.5 Expansion

9.6 Service Launch

9.7 Others

9.8 Inorganic Developments

9.9 Inorganic Growth Strategies In the Healthcare CMO Market, 2015-2018

9.10 Agreement

9.11 Acquisition

9.12 Partnerships

9.13 Collaboration

10. Healthcare CMO Market - Key Company Profiles

10.1 Royal DSM

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Overview

10.1.4 Service Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Catalent Inc.

10.3 Boehringer Ingelheim International GmbH

10.4 Recipharm AB (Publ)

10.5 Fareva

10.6 Lonza

10.7 Piramal Enterprises Ltd.

10.8 Dr. Reddy’s Laboratories Ltd.

10.9 Almac Group

10.10 Famar Health Care Services

For more information about this report visit https://www.researchandmarkets.com/r/jzqu7f

View source version on businesswire.com:https://www.businesswire.com/news/home/20190411005549/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Healthcare Services,Pharmaceutical Manufacturing

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/11/2019 10:28 AM/DISC: 04/11/2019 10:28 AM

http://www.businesswire.com/news/home/20190411005549/en